NICE approves Trabectedin
January 19, 2010Sales and Marketing NICE, PharmaMar, Trabectedin, soft tissue sarcoma
Patients with advanced soft tissue sarcoma could now benefit from PharmaMar’s new drug trabectedin, after the NICE granted its approval. …
US generics company expands into Eastern Europe
January 19, 2010Sales and Marketing Alvogen, Eastern Europe, generics
US generics company Alvogen has announced an ambitious expansion into the lucrative markets of Eastern Europe. The company has opened …
Sir Leszek Borysiewicz to step down from the MRC
January 19, 2010MRC, UK, appointment
The Medical Research Council’s chief executive Sir Leszek Borysiewicz is stepping down later this year to become vice chancellor of …
Avantium appoints Gunnar Staaf
January 19, 2010Sales and Marketing appointment, sales and marketing
Amsterdam-based technology company Avantium has appointed Gunnar Staaf as chief executive of its pharma business in preparation for spinning it …
Pharma responds to disaster in Haiti
January 18, 2010Sales and Marketing Haiti, disaster, industry reputation, relief
A number of pharmaceutical companies have sprung into action to help the relief effort in Haiti. The island has been …
Commission probes Lundbeck on alleged generic blocking
January 18, 2010Sales and Marketing European Commission, Lundbeck, generics, kroes
The European Commission has confirmed it is to investigate Lundbeck for alleged anti-competitive behaviour relating to its anti-depressant Cipramil. The …
NICE to revamp chronic heart failure guidance
January 18, 2010NHS, NICE, chronic heart failure
NICE is moving to update its clinical guidance on the management of chronic heart failure in adults. Draft recommendations are …
Bruce Given appointed chairman of ICON
January 18, 2010Research and Development ICON, appointment, research and development
Irish contract research organisation ICON has appointed Bruce Given chairman.He succeeds out-going chairman John Climax who co-founded the company in 1990 …
Cladribine still set to be first oral MS treatment
January 18, 2010Sales and Marketing Cladribine, FTY-720, MS, Merck Serono
Merck Serono’s new oral treatment for multiple sclerosis cladribine is still tipped to reach the market ahead of its rival, …
Moyes fires parting shots at government
January 18, 2010Monitor, NHS, foundation hospitals
The head of Monitor, the body charged with regulating the leading ‘foundation trust’ hospitals, has aired his views on the …
Cephalon’s pharma chief to step down
January 18, 2010Sales and Marketing Cephalon, appointment, sales and marketing
Cephalon’s executive vice president of worldwide pharmaceutical operations Robert Roche is leaving the company at the beginning of February to …
Talking R&D: Microdosing studies
January 18, 2010Research and Development Microdosing, Talking R&D, Xceleron
A microdose study is performed at an early stage of development in order to obtain preliminary pharmacokinetic or distribution data …
MSI launches Brand Services division
January 18, 2010Sales and Marketing MSI
The MSI Consultancy has launched a new division to help the pharma industry maximise the impact of its brands. The …
Digital Pharma: Byte-sized roundup
January 15, 2010Medical Communications Diagnostics, Novartis, Roche, digital pharma, malaria
In this week’s roundup: Roche answers cancer testing questions, Novartis uses SMS in fight against malaria, UCB goes to Facebook …
NICE dementia guidelines not being followed
January 15, 2010NHS, NHS trusts, NICE, dementia
Few NHS trusts are following NICE’s 2006 guidelines on dementia, according central government auditor the National Audit Office. A NAO …
Fleishman-Hillard recruits BMS external affairs director Richard Marsh
January 15, 2010Medical Communications Fleishman, apppointment, medical communications
Bristol-Myers Squibb’s external affairs director Richard Marsh has moved to PR agency Fleishman-Hillard, where he takes up the role of …
Pfizer signs ‘personalised’ cancer collaboration
January 15, 2010Research and Development Cancer, Debiopharm, Pfizer, melanoma, skin cancer, tremelimumab
Pfizer is to co-develop its monoclonal antibody treatment for advanced melanoma with Swiss company Debiopharm. The companies will conduct phase …
Bristol-Myers Squibb appoints Charles Bancroft acting chief financial officer
January 15, 2010Sales and Marketing BMS, appointment, sales and marketing
Charles Bancroft has been appointed acting chief financial officer at Bristol-Myers Squibb, replacing Jean-Marc Huet who left the company at …
Tories plan public health drive
January 15, 2010Conservatives, NHS, NHS funding, binge drinking, public health
The Department of Health would be renamed the Department of Public Health under a future Tory government, says shadow health …
AstraZeneca taps Korean firm for antibiotics
January 15, 2010Research and Development Asia, AstraZeneca, CrystalGenomics, Korea, anti-infectives
AstraZeneca has signed another licensing deal to bolster its anti-infectives business, this time signing a deal with Korean company CrystalGenomics …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
